coiaward2010

CML Support Groups: Members of the CML Advocates Network

The CML Advocates Network connects patient organisations supporting patients and families affected with Chronic Myeloid Leukemia (CML)

If your group is not listed here, please register. If details have changed, please contact us.

Spain: AELEMIC, Asociación Española Enfermos Leucemia Mieloide Crónica

CONTACT INFORMATION:

Padre Manjon, 25 Entlo. B
03600 Elda ( Alicante)
SPAIN

Tel.: 609865080
Fax: 609865080

E-Mail:
Web: www.aelemic.es

KEY CONTACT:

Mateo Miras Hernandez

President

BRIEF DESCRIPTION OF ORGANIZATION:

AELEMIC is the first patient-led non-profit National Spanish organisation of CML.

AELEMIC is set up in order to share updated information about our disease, progresses and investigations related to CML, as well as to promote and support them.

KEY OBJECTIVES AND INITIATIVES:

Although we are of recent creation (June 2016) we are having AELEMIC I CONFERENCE in November-2016.
Some of our objetives include:
- Sharing updated information about CML.
- Becoming a meeting point for patients.
- Being connector to public institutions, national or international issues.
- Defend CML patient-rights.
- Improving the quality of life and survival by providing specialised information in Nutririonist and Psycologist´s blogs.
- Organising conferences, colloquium, chats.... that can help patients in the daily management of the disease.

MEMBERS:

60


 
   
 

Please donate!

Please donate!

Tweet Feed

LMC_PACIENTES
From 26 April “Sprycel is indicated for the treatment of paediatric patients with: newly diagnosed Ph+ CML in chron… twitter.com/i/web/status/9…

Retweeted Saturday, 19 May 2018

ZPWLC
Progress is impossible without change and those who cannot change their minds cannot change anything... 🤔 #Quotetwitter.com/i/web/status/9…

Retweeted Sunday, 13 May 2018

LMC_PACIENTES
Encuesta Parada de tratamiento #TFR4CML En #CMLHZ18 vimos primeros resultados sobre 600 respuestas ya recibidas a l… twitter.com/i/web/status/9…

Retweeted Wednesday, 09 May 2018